Consensus Guidelines for the Selection and Implantation of Patients With Noncancer Pain for Intrathecal Drug Delivery
Timothy R. Deer , Michael Cousins , Peter S. Staats , Lynn R. Webster
Pain Physician 13 ( 3)
48
2010
Best Practices: Eight Principles for Safer Opioid Prescribing
Lynn R. Webster
2015
Guide to Aberrant Drug-Related Behavior When Prescribing Opioids for Pain Management
Lynn R. Webster
2015
Consensus Recommendations on Initiating Prescription Therapies for Opioid-Induced Constipation
Charles E. Argoff , Michael J. Brennan , Michael Camilleri , Andrew Davies
Pain Medicine 16 ( 12) 2324 -2337
69
2015
Opioid Therapy and Sleep Disorders: Risks and Mitigation Strategies.
Martin D. Cheatle , Lynn R. Webster
Pain Medicine 16
33
2015
A Responsible Way to Treat Patients and Pain
Lynn R. Webster
Pain Medicine 14 ( 5) 615 -616
2013
Fentanyl Buccal Tablet Compared with Immediate‐Release Oxycodone for the Management of Breakthrough Pain in Opioid‐Tolerant Patients with Chronic Cancer and Noncancer Pain: A Randomized, Double‐Blind, Crossover Study Followed by a 12‐Week Open‐Label Phase to Evaluate Patient Outcomes
Lynn R. Webster , Kieran A. Slevin , Arvind Narayana , Craig Q. Earl
Pain Medicine 14 ( 9) 1332 -1345
21
2013
Eight principles for safer opioid prescribing.
Lynn R. Webster
Pain Medicine 14 ( 7) 959 -961
10
2013
Benzodiazepines in Long-Term Opioid Therapy
Gary M. Reisfield , Lynn R. Webster
Pain Medicine 14 ( 10) 1441 -1446
20
2013
Pills, Polices, and Predicaments: The Unintended Consequences of a Health Care System's Policy toward Opioids
Lynn R. Webster
Pain Medicine 14 ( 10) 1439 -1440
7
2013
New policing role for pharmacists undermines partnership with prescribers.
Lynn R. Webster
Pain Medicine 14 ( 11) 1619 -1620
5
2013
Why we need narratives of healing and qualitative pain research
R. Norman Harden , Lynn R. Webster
Pain Medicine 14 ( 12) 1811 -1812
6
2013
Pain and suicide: the other side of the opioid story.
Lynn R. Webster
Pain Medicine 15 ( 3) 345 -346
11
2014
It Takes Many True Leaders to Become a Top‐Tier Pain Organization
Lynn R. Webster
Pain Medicine 15 ( 1) 3 -3
2014
Comparative Effects of Morning vs Evening Dosing of Extended-Release Hydromorphone on Sleep Physiology in Patients with Low Back Pain: A Pilot Study
Lynn R. Webster , Michael D. Smith , Sam Mackin , Matthew Iverson
Pain Medicine 16 ( 3) 460 -471
8
2015
The Relationship Between the Mechanisms of Action and Safety Profiles of Intrathecal Morphine and Ziconotide: A Review of the Literature
Lynn R. Webster
Pain Medicine 16 ( 7) 1265 -1277
27
2015
Long-Term Intrathecal Ziconotide for Chronic Pain: An Open-Label Study
Lynn R. Webster , Robert Fisher , Steven Charapata , Mark S. Wallace
Journal of Pain and Symptom Management 37 ( 3) 363 -372
50
2009
Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain.
David M. Simpson , Suzanne Gazda , Stephen Brown , Lynn R. Webster
Journal of Pain and Symptom Management 39 ( 6) 1053 -1064
106
2010
Long-Term Safety and Efficacy of Morphine Sulfate and Naltrexone Hydrochloride Extended Release Capsules, a Novel Formulation Containing Morphine and Sequestered Naltrexone, in Patients with Chronic, Moderate to Severe Pain
Lynn R. Webster , Randall Brewer , Chao Wang , Doreen Sekora
Journal of Pain and Symptom Management 40 ( 5) 734 -746
31
2010
Desmetramadol Has the Safety and Analgesic Profile of Tramadol Without Its Metabolic Liabilities: Consecutive Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Trials.
John A. Zebala , Shawn L. Searle , Lynn R. Webster , Matt S. Johnson
The Journal of Pain 20 ( 10) 1218 -1235
4
2019